1. Home
  2. SPRC vs SCNI Comparison

SPRC vs SCNI Comparison

Compare SPRC & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • SCNI
  • Stock Information
  • Founded
  • SPRC 2004
  • SCNI 2003
  • Country
  • SPRC Israel
  • SCNI Israel
  • Employees
  • SPRC N/A
  • SCNI N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SPRC Health Care
  • SCNI Health Care
  • Exchange
  • SPRC Nasdaq
  • SCNI Nasdaq
  • Market Cap
  • SPRC 4.3M
  • SCNI 4.6M
  • IPO Year
  • SPRC N/A
  • SCNI N/A
  • Fundamental
  • Price
  • SPRC $2.78
  • SCNI $1.07
  • Analyst Decision
  • SPRC
  • SCNI
  • Analyst Count
  • SPRC 0
  • SCNI 0
  • Target Price
  • SPRC N/A
  • SCNI N/A
  • AVG Volume (30 Days)
  • SPRC 289.9K
  • SCNI 79.8K
  • Earning Date
  • SPRC 01-01-0001
  • SCNI 11-24-2025
  • Dividend Yield
  • SPRC N/A
  • SCNI N/A
  • EPS Growth
  • SPRC N/A
  • SCNI N/A
  • EPS
  • SPRC N/A
  • SCNI 0.26
  • Revenue
  • SPRC $1,306,000.00
  • SCNI $1,147,000.00
  • Revenue This Year
  • SPRC N/A
  • SCNI N/A
  • Revenue Next Year
  • SPRC N/A
  • SCNI N/A
  • P/E Ratio
  • SPRC N/A
  • SCNI $3.98
  • Revenue Growth
  • SPRC N/A
  • SCNI 303.87
  • 52 Week Low
  • SPRC $1.75
  • SCNI $1.00
  • 52 Week High
  • SPRC $37.59
  • SCNI $6.18
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 37.96
  • SCNI 36.96
  • Support Level
  • SPRC $2.51
  • SCNI $1.00
  • Resistance Level
  • SPRC $3.40
  • SCNI $1.55
  • Average True Range (ATR)
  • SPRC 0.22
  • SCNI 0.11
  • MACD
  • SPRC -0.08
  • SCNI -0.04
  • Stochastic Oscillator
  • SPRC 17.47
  • SCNI 19.99

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: